Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of EC0489 for the Treatment of Refractory or Metastatic Tumors

This study has been completed.
Information provided by (Responsible Party):
Endocyte Identifier:
First received: February 25, 2009
Last updated: August 7, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)